The Institute for Policy Innovation (IPI) is a free-market policy think tank that focuses on issues related to economic growth, innovation, limited government and individual liberty. Thanks for visiting! Please take a look around and sign up for updates. We welcome your support for our work.
Compulsory licensing deters innovators from investing in drug discovery. It won’t reduce what patients pay.
Americans are the world’s top users of generics, but not of biosimilars. State and local governments should encourage a wider uptake for their own employees as an important start—and a much-needed cost savings.